Similarly, the myocardial injury marker H-FABP showed a remarkable predictive power for severity progression, where serum levels in patients were consistently elevated with progressive infection severity scores, which agrees with the recent study of Yin et al. [42] proposing serum H-FABP as a predictive biomarker for COVID-19 severity. The gene discussed is FABP3; the disease is infection.